NVCR

17.61

2.28% -0.41

Dopo l'orario di chiusura: 17.61

Novocure Ltd (NVCR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché NVCR Giù? Forum Previsione

Precedente Chiudi:

$18.02

Aprire:

$17.7

Volume 24 ore:

533.55K

Relative Volume:

0.40

Capitalizzazione di mercato:

$1.91B

Reddito:

$525.66M

Utile/perdita netta:

$-192.74M

Rapporto P/E:

-9.4677

EPS:

-1.86

Flusso di cassa netto:

$-120.97M

1 W Prestazione:

+2.21%

1M Prestazione:

-1.62%

6M Prestazione:

+27.42%

1 anno Prestazione:

-6.43%

Intervallo 1D:

$17.24

$18.59

Intervallo di 1 settimana:

$16.71

$18.86

Portata 52W:

$10.87

$24.73

Novocure Ltd Stock (NVCR) Company Profile

Nome

Novocure Ltd

Settore

Healthcare (1183)

Industria

Medical Devices (154)

Telefono

44 (0)15 3475 6700

Indirizzo

NO. 4 THE FORUM, ST. HELIER

Dipendente

1,453

Cinguettio

@novocure

Prossima data di guadagno

2024-07-25

Ultimi documenti SEC

NVCR's Discussions on Twitter

Novocure Ltd Stock (NVCR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-08-28	Downgrade	H.C. Wainwright	Buy → Neutral
2023-08-08	Aggiornamento	Piper Sandler	Neutral → Overweight
2023-08-04	Iniziato	SVB Securities	Outperform
2023-07-31	Aggiornamento	Evercore ISI	Underperform → In-line
2023-06-07	Aggiornamento	Wedbush	Underperform → Neutral
2023-05-16	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2023-03-17	Downgrade	JP Morgan	Neutral → Underweight
2023-01-06	Downgrade	Wells Fargo	Overweight → Equal Weight
2023-01-05	Reiterato	H.C. Wainwright	Buy
2022-11-29	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2022-10-24	Downgrade	Piper Sandler	Overweight → Neutral
2022-07-05	Downgrade	Evercore ISI	In-line → Underperform
2022-05-16	Iniziato	H.C. Wainwright	Buy
2022-02-08	Iniziato	Loop Capital	Buy
2022-02-02	Aggiornamento	Oppenheimer	Perform → Outperform
2022-01-20	Aggiornamento	Truist	Hold → Buy
2022-01-03	Aggiornamento	Evercore ISI	Underperform → In-line
2021-07-01	Downgrade	Mizuho	Buy → Neutral
2021-04-14	Downgrade	Wedbush	Neutral → Underperform
2021-01-25	Reiterato	Piper Sandler	Overweight
2020-09-23	Iniziato	Northland Capital	Outperform
2020-09-18	Downgrade	Wells Fargo	Overweight → Equal Weight
2020-09-17	Downgrade	Truist	Buy → Hold
2020-06-01	Ripresa	Oppenheimer	Perform
2020-05-01	Downgrade	Oppenheimer	Outperform → Perform
2020-04-09	Downgrade	Evercore ISI	In-line → Underperform
2020-03-05	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2020-01-02	Downgrade	Evercore ISI	Outperform → In-line
2019-07-29	Aggiornamento	SunTrust	Hold → Buy
2019-07-26	Downgrade	JP Morgan	Overweight → Neutral
2019-07-26	Downgrade	Wedbush	Outperform → Neutral
2019-03-20	Iniziato	SunTrust	Hold
2018-11-02	Downgrade	Wells Fargo	Outperform → Market Perform
2018-07-16	Iniziato	Evercore ISI	Outperform
2018-04-18	Reiterato	Mizuho	Buy
2018-02-23	Reiterato	Mizuho	Buy
2017-05-24	Aggiornamento	Wells Fargo	Market Perform → Outperform
2016-07-29	Reiterato	Wedbush	Outperform
2016-01-19	Iniziato	Barclays	Underweight
2015-12-02	Iniziato	Deutsche Bank	Hold

Mostra tutto

Novocure Ltd Borsa (NVCR) Ultime notizie

05:28 AM

A company insider recently sold 688 shares of NovoCure Ltd [NVCR]. Should You also Consider to Sale? - Knox Daily

05:28 AM

12:28 PM

Analytical Lens: Exploring NovoCure Ltd (NVCR)’s Financial Story Through Ratios - The Dwinnex

12:28 PM

09:02 AM

A year in review: NovoCure Ltd (NVCR)’s performance in the last year - US Post News

09:02 AM

Sep 16, 2024

Taking on analysts’ expectations and winning: NovoCure Ltd (NVCR) - SETE News

Sep 16, 2024

Sep 13, 2024

Chief Financial Officer Cordova Ashley sold 688 shares of NovoCure Ltd [NVCR] - Knox Daily

Sep 13, 2024

Sep 12, 2024

Investors Appear Satisfied With NovoCure Limited's (NASDAQ:NVCR) Prospects - Simply Wall St

Sep 12, 2024

Sep 11, 2024